Furthermore, as seen in the training set, TFPI2 levels >345 pg/mL were also observed in a subset of patients with serous-type EOC (5 of 17) or endometrioid-type endometrial cancer (2 of 26) (S1 Table). The gene discussed is TFPI2; the disease is endometrial cancer.